TrialBreast cancer research : BCR2020

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial.

Amelie de Gregorio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.